AI in Health Care: Balancing Benefits and Barriers
AI can help alleviate the burden on clinical labs—but only with sufficient investment, enthusiasm, and understanding
Diagnostic Testing and Emerging Technologies
Keeps You Up-to-Date on New Diagnostic Tests, Testing Trends and Opportunities, and Emerging Test Technologies
Esophageal Pre-Cancer Testing Gaining Greater Traction
How three companies are addressing screening challenges with tests that help improve chances of early detection
Computing the Future of the Lab
Computational biology expert Keaun Amani shares his advice and insights on AI and machine learning tools for the clinical lab
PSA Screening Cost Effective With ‘Smarter’ Approach
...
This content is for Paid Members only.
Register
Register
Already a member? Log in here
VolitionRx Uses Nucleosome Technology for Early Cancer Diagnosis
...
This content is for Paid Members only.
Register
Register
Already a member? Log in here
Disease-Causing Variants Often Occur Outside of ‘High-Confidence’ Sequence Areas
...
This content is for Paid Members only.
Register
Register
Already a member? Log in here
Methylation Patterns Are New Target for ctDNA Analysis
...
This content is for Paid Members only.
Register
Register
Already a member? Log in here
Disposable, Electrochemical Sensor IDs Wound Infections in Seconds
...
This content is for Paid Members only.
Register
Register
Already a member? Log in here
Adherence Poor for Lynch Syndrome Testing
...
This content is for Paid Members only.
Register
Register
Already a member? Log in here
Few DTC Genetic Test Customers Share Results With Health Providers
From - Diagnostic Testing & Emerging Technologies
While few direct-to-consumer (DTC) genetic testing consumers share their results with a health care provider, most who do are satisfied with the discussion of results…
Survey Finds Expected Growth in Analytical Instrumentation Purchases
From - Diagnostic Testing & Emerging Technologies
A new survey reveals that laboratories are planning to increase equipment purchases this year, with analytical instrumentation reported…
Genetic Risk of Disease Results Don’t Change Health-Related Behaviors
From - Diagnostic Testing & Emerging Technologies
Communicating genetic risk of disease estimates does not impact individuals' health related behaviors, according to a review published March 15 in the…
New Breast Cancer Staging System Incorporates HER2 Status to Better Assess Prognosis
From - Diagnostic Testing & Emerging Technologies
A new breast cancer staging system adds HER2 (ERBB2-positive disease) status to a list of factors used to assess prognosis in women who undergo neoadjuvant (pre-surgical) therapy for…
